$7.5M of EBITDA making superhero minifigures! Our favorite deal ever? - Acquisitions Anonymous 207
$7.5M of EBITDA making superhero minifigures! Our favorite deal ever? - Acquisitions Anonymous 207
Bill D’Alessandro (@ BillDA ), and Heather Endresen ( @EndresenHeather ) review a deal for a company that produces collectible statues. Let us know what you think. Today's deal comes from Axial . ...
Bill D’Alessandro (@BillDA), and Heather Endresen (@EndresenHeather) review a deal for a company that produces collectible statues. Let us know what you think.
Today's deal comes from Axial. Axial is a trusted deal sourcing platform serving professional acquirers in the American lower middle market.
Axial partners with over 2,000 boutique investment bankers and business brokers who use the Axial platform to market their deals to lower middle market acquirers.
Sweetspot on Axial in terms of deal size is from $5M to $75M in enterprise value, located solely within the US and Canada.
Deal activity occurs in five industry verticals: manufacturing, tech / IT services, healthcare, B2B services, and consumer.
- Do you love Acquanon and want to see our smiling faces? Subscribe to our Youtube channel.
- Do you enjoy our content? Rate our show!
- Follow us on Twitter @acquanon Learnings about small business acquisitions and operations.
Episode Transcript
More Episodes
The $10M “AI Anti-Aging Bed” That Might Be Too Weird to Be Real
In this episode the hosts analyze a bizarre AI-powered therapeutic bed business with strong profits but questionable positioning, confusing pricing, and a whiff of pseudo-science risk.
This Franchise Cleans Fryer Oil… But Is It Profitable?
In this episode the hosts debate a commercial kitchen oil filtration franchise that most liked for its recurring revenue potential, while one host strongly opposed it due to small market size, customer churn risk, and dependence on struggling restaurants.
Would You Buy This Healthcare SaaS? (Birth Tracking App)
In this episode the hosts analyze a tiny niche SaaS serving midwives and doulas with 80% margins but conclude the $400K price is too high given zero growth, easy replication risk, and limited market traction.